Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: A case series

被引:7
|
作者
Cantisani, Carmen [1 ]
Naqeshbandi, Ahmad Faiq [1 ]
Goldust, Mohamad [2 ]
Lampitelli, Salvatore [1 ]
Cantoresi, Franca [1 ]
Alsorori, Ezeldeen [3 ]
机构
[1] Umberto I Hosp, Sapienza Med Sch Rome, UOC Dermatol, Rome, Italy
[2] Mazandaran Univ Med Sci, Dept Dermatol, Sari, Iran
[3] Univ Sci & Technol Hosp, Dept Dermatol, Sanaa, Yemen
关键词
adhesion defects; bacterial infections; primary immunodeficiencies;
D O I
10.1111/dth.12864
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Primary immunodeficiencies are rare, inherited diseases, characterized by altered function or absence of immune cells. Among them is leukocyte adhesion deficiency Type I (LAD-I), an autosomal recessive disorder characterized by primary immunodeficiency, caused by mutations in the ITGB2 gene which produces inability of leucocytes to migrate toward the area of inflammation and is associated with recurrent life-threatening bacterial and fungal infections. Pyoderma gangrenosum (PG) is an uncommon noninfectious neutrophilic dermatosis, characterized by recurrent, necrotic ulcers. It is a diagnosis of exclusion and can be challenging and its management is empirical, with local (topical tacrolimus or intralesional triamcinolone) or systemic immunosuppressive therapy (oral or intravenous glucocorticoids, sulfasalazine, especially in cases associated with Crohn's disease, cyclosporine and, recently, anti-tumor necrosis factor drugs such as Infliximab, Etanercept, and Adalimumab). Though skin ulcerations are common, predominant clinical presentation as PG can often mimic other diseases. It is unusual in children even more in LAD-I. Here, we present a Yemenian family with LAD-I from consanguineous relatives. All patients had history of chronic recurrent skin ulcerations without any bleeding tendency, associated with persistent neutrophilia and requiring steroids and antibiotics. There was no history of delayed cord separation and the condition was initially diagnosed as epidermolysis bullosa, but successively as PG. LAD-I should be kept in mind while evaluating patients with PG especially in children with persistent neutrophilia in the absence of other rheumatological disorders. Its diagnosis is extremely important from the management perspective, as treating these patients without adequate antibiotic cover may be fatal, as happened to one of our patient, and these patients often require hematopoietic stem cell transplantation for permanent cure. Therefore, genetic counseling especially in population with high consanguinity is mandatory.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] A CASE OF THE CHITOTRIOSIDASE DEFICIENCY IN PATIENT WITH GAUCHER DISEASE TYPE I
    Olkhovych, N., V
    Pichkur, N. O.
    Ivanova, T. P.
    Trofimova, N. S.
    Nedoboy, A. N.
    Kormoz, S. N.
    Gorovenko, N. G.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S218 - S218
  • [42] Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I
    Yamashita, Motoi
    Eguchi, Shiori
    Tomomasa, Dan
    Kamiya, Takahiro
    Niizato, Daiki
    Mitsuiki, Noriko
    Isoda, Takeshi
    Funakoshi, Hanako
    Mizuno, Yuki
    Okamoto, Kentaro
    Nguyen, Tuan Minh
    Takada, Hidetoshi
    Takagi, Masatoshi
    Imai, Kohsuke
    Morio, Tomohiro
    Kanegane, Hirokazu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Molecular and clinical spectrum of type I plasminogen deficiency:: a series of 50 patients
    Tefs, Katrin
    Gueorguieva, Maria
    Klammt, Juergen
    Allen, Carl M.
    Aktas, Dilek
    Anlar, Fehim Y.
    Aydogdu, Sultan D.
    Brown, Deborah
    Ciftci, Ergin
    Contarini, Patricia
    Dempfle, Carl-Erik
    Dostalek, Miroslav
    Eisert, Susanne
    Gokbuget, Aslan
    Gunhan, Omer
    Hidayat, Ahmed A.
    Hugle, Boris
    Isikoglu, Mete
    Irkec, Murat
    Joss, Shelagh K.
    Klebe, Sonja
    Kneppo, Carolin
    Kurtulus, Idil
    Mehta, Rakesh P.
    Ornek, Kemal
    Schneppenheim, Reinhard
    Seregard, Stefan
    Sweeney, Elizabeth
    Turtschi, Stephanie
    Veres, Gabor
    Zeitler, Petra
    Ziegler, Maike
    Schuster, Volker
    BLOOD, 2006, 108 (09) : 3021 - 3026
  • [44] A FAMILY WITH TYPE-I CONGENITAL PLASMINOGEN DEFICIENCY HAVING NO HISTORY OF THROMBOSIS
    INOMOTO, T
    MIYA, K
    FUJINO, O
    OKA, K
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1297 - 1297
  • [45] Comprehensive preclinical studies for the gene therapy of patients with leukocyte adhesion deficiency type I (LAD-I)
    Almarza, E.
    Mesa-Nunez, C.
    Damian, C.
    Diez-Cabezas, B.
    Fernandez-Garcia, M.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A28 - A28
  • [46] Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
    Li, Wendao
    Wang, Wei
    Zhong, Linqing
    Gou, Lijuan
    Wang, Changyan
    Ma, Jingran
    Quan, Meiying
    Jian, Shan
    Tang, Xiaoyan
    Zhang, Yu
    Wang, Lin
    Ma, Mingsheng
    Song, Hongmei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] LEUKOCYTE ADHESION DEFICIENCY IN A DUTCH HOLSTEIN CALF - A CASE WITH A CLEAR-CUT FAMILY HISTORY
    BERNADINA, WE
    DUITS, AJ
    KALSBEEK, HC
    WENSING, T
    LEIBOLD, W
    ELVING, L
    WENTINK, GH
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 37 (3-4) : 295 - 308
  • [48] Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation
    Anis, Sabiha
    Abid, Aiysha
    Kodwavwala, Sadaf Aba Umer
    Sarfaraz, Sabahat
    Junejo, Samina
    Shahid, Saba
    Sultan, Sajid
    Rizvi, Adibul Hasan
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [49] Leukocyte Adhesion Deficiency Type III: Clinical Features and Treatment With Stem Cell Transplantation
    Stepensky, Polina Y.
    Wolach, Baruch
    Gavrieli, Ronit
    Rousso, Sharon
    Ben Ami, Tal
    Goldman, Vladimir
    Rozovsky, Katya
    Hanna, Suhair
    Etzioni, Amos
    Weintraub, Michael
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (04) : 264 - 268
  • [50] Treatment of pyoderma gangrenosum (PG) with infliximab in leukocyte adhesion deficiency (LAD) type 1
    Shanks, KP
    Popek, EJ
    Abramson, SL
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S282 - S283